This product is a central anticholinergic anti-Parkinson's disease drug that selectively blocks the cholinergic nerve pathways in the striatum, but has less effect on the periphery, thus helping to restore the balance of dopamine and acetylcholine in the brain of Parkinson's patients and improve the patients' Parkinson's disease symptoms.

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia, Chlamydia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

Vitamin B2 is a component of coenzyme, involved in the metabolism of sugar, protein, and fat, maintaining normal visual function and promoting growth.

Progestogens act on the endometrium and promote the proliferation and secretion of the endometrium. Through negative feedback to the hypothalamus, they inhibit the release of luteinizing hormone from the anterior pituitary and inhibit the ovulation process of the ovary. The anti-cancer effect may be related to the anti-estrogen effect.

After entering the body, it can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic compounds that are excreted in the urine, which has the effect of protecting the liver and detoxifying. In addition, glucuronic acid can increase the content of liver glycogen and reduce fat reserves.

After entering the body, glucuronide can combine with poisons containing hydroxyl or carboxyl groups to form low-toxic or non-toxic combinations that are excreted in the urine, which has the effect of protecting the liver and detoxifying. In addition, glucuronic acid can increase the glycogen content of the liver and reduce fat reserves. Vitamin B1 combines with adenosine triphosphate to form vitamin B1 pyrophosphate (thiamine triphosphate, cocarboxylase), which is a coenzyme necessary for carbohydrate metabolism; vitamin B1 can inhibit the activity of cholinesterase. When it is deficient, the activity of cholinesterase increases, the hydrolysis of acetylcholine is accelerated, and the conduction of nerve impulses is impaired, affecting gastrointestinal and myocardial functions. This product is mainly absorbed in the duodenum, metabolized in the liver, and excreted through the kidneys.

It combines with adenosine triphosphate to form vitamin B1 pyrophosphate (thiamine triphosphate, cocarboxylase), which is a coenzyme necessary for carbohydrate metabolism; it can inhibit the activity of cholinesterase. When it is deficient, the activity of cholinesterase increases, the hydrolysis of acetylcholine is accelerated, causing nerve impulse conduction disorders, and affecting gastrointestinal and myocardial function.